Butein suppresses the expression of nuclear factor-kappa B-mediated matrix metalloproteinase-9 and vascular endothelial growth factor in prostate cancer cells

Toxicology in Vitro

Volumn 24, Issue 7, 2010, Pages 1927-1934

  Moon, Dong Oh ^a   Choi, Yung Hyun ^b,c   Moon, Sung Kwon ^b,d   Kim, Wun Jae ^b,e   Kim, Gi Young ^a,b  

^a Jeju National University   (South Korea)

^b Chungbuk National University   (South Korea)

^c Dong Eui University   (South Korea)

^d Chungju National University   (South Korea)

^e Chungbuk National University College of Medicine   (South Korea)

Author keywords

Butein; Matrix metalloproteinase 9; Nuclear factor B; Vascular endothelial growth factor

Indexed keywords

BUTEIN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHORBOL 12 ACETATE 13 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INVASION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; PROSTATE CANCER; PROTEIN EXPRESSION;

ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHALCONES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; PROSTATIC NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77957020140     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2010.08.002     Document Type: Article

References (40)

1. Balbay M.D., Pettaway C.A., Kuniyasu H., Inoue K., Ramirez E., Li E., Fidler I.J., Dinney C.P. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor. Clin. Cancer Res. 1999, 5:783-789.
2. Barnes P.J., Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 1997, 336:1066-1071.
3. Curran S., Murray G.I. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur. J. Cancer 2000, 36:1621-1630.
4. Dong Z., Bonfil R.D., Chinni S., Deng X., Trindade Filho J.C., Bernardo M., Vaishampayan U., Che M., Sloane B.F., Sheng S., Fridman R., Cher M.L. Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue. Am. J. Pathol. 2005, 166:1173-1186.
5. Eferl R., Wagner E.F. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 2003, 3:859-868.
6. Fidler I.J. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res. 1990, 50:6130-6138.
7. Greenlee R.T., Murray T., Bolden S., Wingo P.A. Cancer statistics, 2000. CA Cancer J. Clin. 2000, 50:7-33.
8. Hamdy F.C., Fadlon E.J., Cottam D., Lawry J., Thurrell W., Silcocks P.B., Anderson J.B., Williams J.L., Rees R.C. Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia. Br. J. Cancer 1994, 69:177-182.
9. Himelstein B.P., Canete-Soler R., Bernhard E.J., Dilks D.W., Muschel R.J. Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion Metastasis 1994-1995, 14:246-258.
10. Huang S., Pettaway C.A., Uehara H., Bucana C.D., Fidler I.J. Blockade of NF-κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene 2001, 20:4188-4197.
11. Iwashita K., Kobori M., Yamaki K., Tsushida T. Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells. Biosci. Biotechnol. Biochem. 2000, 64:1813-1820.
12. Jang H.S., Kook S.H., Son Y.O., Kim J.G., Jeon Y.M., Jang Y.S., Choi K.C., Kim J., Han S.K., Lee K.Y., Park B.K., Cho N.P., Lee J.C. Flavonoids purified from Rhus verniciflua Stokes actively inhibit cell growth and induce apoptosis in human osteosarcoma cells. Biochim. Biophys. Acta 2005, 1726:309-316.
13. John A., Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol. Oncol. Res. 2001, 7:14-23.
14. Jung C.H., Kim J.H., Hong M.H., Seog H.M., Oh S.H., Lee P.J., Kim G.J., Kim H.M., Um J.Y., Ko S.G. Phenolic-rich fraction from Rhus verniciflua Stokes (RVS) suppress inflammatory response via NF-κB and JNK pathway in lipopolysaccharide-induced RAW 264.7 macrophages. J. Ethnopharmacol. 2007, 110:490-497.
15. Jung M.H., Lee S.H., Ahn E.M., Lee Y.M. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway. Carcinogenesis 2009, 30:655-661.
16. Kang D.G., Lee A.S., Mun Y.J., Woo W.H., Kim Y.C., Sohn E.J., Moon M.K., Lee H.S. Butein ameliorates renal concentrating ability in cisplatin-induced acute renal failure in rats. Biol. Pharm. Bull. 2004, 27:366-370.
17. Kang H.M., Kim J.H., Lee M.Y., Son K.H., Yang D.C., Baek N.I., Kwon B.M. Relationship between flavonoid structure and inhibition of farnesyl protein transferase. Nat. Prod. Res. 2004, 18:349-356.
18. Kong D., Li Y., Wang Z., Banerjee S., Sarkar F.H. Inhibition of angiogenesis and invasion by 3,3'-diindolymethane is mediated by the NF-κB downstream target genes MMP-9 and uPA that regulated bioavailability of VEGF in prostate cancer. Cancer Res. 2007, 67:3310-3319.
19. Landis S.H., Murray T., Bolden S., Wingo P.A. Cancer statistics, 1999. CA Cancer J. Clin. 1999, 49:8-31.
20. Lee J.C., Lee K.Y., Kim J., Na C.S., Jung N.C., Chung G.H., Jang Y.S. Extract from Rhus verniciflua Stokes is capable of inhibiting the growth of human lymphoma cells. Food Chem. Toxicol. 2004, 42:1383-1388.
21. Lee S.H., Seo G.S., Sohn D.H. Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase by butein in RAW 264.7 cells. Biochem. Biophys. Res. Commun. 2004, 323:125-132.
22. Lim S.S., Jung S.H., Ji J., Shin K.H., Keum S.R. Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues. J. Pharm. Pharmacol. 2001, 53:653-668.
23. Nakano H., Shindo M., Sakon S., Nishinaka S., Mihara M., Yagita H., Okumura K. Differential regulation of IκB kinase alpha and beta by two upstream kinases, NF-κB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc. Natl. Acad. Sci. USA 1998, 95:3537-3542.
24. Overall C.M., Wrana J.L., Sodek J. Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J. Biol. Chem. 1989, 264:1860-1869.
25. Palayoor S.T., Youmell M.Y., Calderwood S.K., Coleman C.N., Price B.D. Constitutive activation of IκB kinase alpha and NF-κB in prostate cancer cells is inhibited by ibuprofen. Oncogene 1999, 18:7389-7394.
26. Pandey M.K., Sandur S.K., Sung B., Sethi G., Kunnumakkara A.B., Aggarwal B.B. Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-κB and NF-κB-regulated gene expression through direct inhibition of IκBα kinase beta on cystein 179 residue. J. Biol. Chem. 2007, 282:17340-17350.
27. Pandey M.K., Sung B., Ahn K.S., Aggarwal B.B. Butein suppresses constitutive and inducible signal transducer and activator of transcription (STAT) 3 activation and STAT3-regulated gene products through the induction of a protein tyrosine phosphatase SHP-1. Mol. Pharmacol. 2009, 75:525-533.
28. Qin J.Z., Chaturvedi V., Denning M.F., Choubey D., Diaz M.O., Nickoloff B.J. Role of NF-κB in the apoptotic-resistant phenotype of keratinocytes. J. Biol. Chem. 1999, 274:37957-37964.
29. Ramanathan R., Tan C.H., Das N.P. Cytotoxic effect of plant polyphenols and fat-soluble vitamins on malignant human cultured cells. Cancer Lett. 1992, 62:217-224.
30. Samoszuk M., Tan J., Chorn G. The chalcone butein from Rhus verniciflua Stokes inhibits clonogenic growth of human breast cancer cells co-cultured with fibroblasts. BMC Complement Altern. Med. 2005, 5:1-5.
31. Selvam C., Jachak S.M., Bhutani K.K. Cyclooxygenase inhibitory flavonoids from the stem bark of Semecarpus anacardium Linn. Phytother. Res. 2004, 18:582-584.
32. Takada Y., Singh S., Aggarwal B.B. Identification of a p65 peptide that selectively inhibits NF-κB activation induced by various inflammatory stimuli and its role in down-regulation of NF-κB-mediated gene expression and up-regulation of apoptosis. J. Biol. Chem. 2004, 279:15096-15104.
33. Verma I.M., Stevenson J.K., Schwarz E.M., Van Antwerp D., Miyamoto S. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 1995, 9:2723-2735.
34. Wang Y., Chan F.L., Chen S., Leung L.K. The plant polyphenol butein inhibits testosterone-induced proliferation in breast cancer cells expressing aromatase. Life Sci. 2005, 77:39-51.
35. Woo J.H., Lim J.H., Kim Y.H., Suh S.I., Min D.S., Chang J.S., Lee Y.H., Park J.W., Kwon T.K. Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene 2004, 23:1845-1853.
36. Yit C.C., Das N.P. Cytotoxic effect of butein on human colon adenocarcinoma cell proliferation. Cancer Lett. 1994, 82:65-72.
37. Yokoo T., Kitamura M. Dual regulation of IL-1beta-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-κB and AP-1. Am. J. Physiol. 1996, 270:123-130.
38. Yoshida S., Ono M., Shono T., Izumi H., Ishibashi T., Suzuki H., Kuwano M. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol. Cell. Biol. 1997, 17:4015-4023.
39. Yu Y., Sato J.D. MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor. J. Cell. Physiol. 1999, 178:235-246.
40. Zhang L., Chen W., Li X. A novel anticancer effect of butein: inhibition of invasion through the ERK1/2 and NF-κB signaling pathways in bladder cancer cells. FEBS Lett. 2008, 582:1821-1828.